Association between Circulating Protein C Levels and Incident Dementia: The Atherosclerosis Risk in Communities Study.


Journal

Neuroepidemiology
ISSN: 1423-0208
Titre abrégé: Neuroepidemiology
Pays: Switzerland
ID NLM: 8218700

Informations de publication

Date de publication:
2021
Historique:
received: 03 02 2021
accepted: 30 03 2021
pubmed: 3 6 2021
medline: 29 10 2021
entrez: 2 6 2021
Statut: ppublish

Résumé

Hemostasis depends on the delicate balance between coagulants and anticoagulants. Higher levels of circulating coagulants have been associated with higher risk of cerebral infarctions and dementia. In contrast, higher levels of circulating protein C, an endogenous anticoagulant, have been associated with lower risk of cerebral infarctions, and the association between protein C levels and the risk of dementia is unknown. The goal of this study was to evaluate the association of circulating protein C levels in midlife and late life with incident dementia. Circulating protein C levels were measured using blood samples collected at the midlife baseline (1987-1989) and the late-life baseline (2011-2013) among 14,462 and 3,614 participants, respectively, in the Atherosclerosis Risk in Communities study. Protein C levels were measured using enzyme-linked immunosorbent assay at midlife and a modified aptamer-based assay at late life. Participants were followed up to 2013 from midlife and up to 2017 from late life. Incident dementia was ascertained during the follow-up periods using in-person cognitive and functional assessment, informant interviews, and International Classification of Diseases codes at hospitalization discharge and on death certificates. Cause-specific Cox regression models were used to evaluate the association between quintiles of circulating protein C and incident dementia. From midlife (mean age of 54), 1,389 incident dementia events were observed over a median follow-up of 23 years. From late life (mean age of 75), 353 incident dementia events were observed over a median follow-up of 4.9 years. At both midlife and late life, circulating protein C had an inverse association with incident dementia after adjusting for demographic, vascular, and hemostatic risk factors, incident stroke as time-dependent covariate, and incorporating stabilized weights based on propensity scores (quintile 5 vs. quintile 1 as the reference, midlife hazard ratio 0.80, 95% confidence interval 0.66-0.96, p value for trend 0.04; late-life hazard ratio 0.84, 95% confidence interval: 0.55-1.28, p value for trend 0.04). Circulating protein C has an inverse association with incident dementia independent of established risk factors, including stroke. Our results suggest studying anticoagulants in addition to coagulants can increase our understanding on the relationship between hemostasis and dementia.

Identifiants

pubmed: 34077937
pii: 000516287
doi: 10.1159/000516287
pmc: PMC8292178
mid: NIHMS1694759
doi:

Substances chimiques

Protein C 0

Types de publication

Journal Article Research Support, N.I.H., Extramural

Langues

eng

Sous-ensembles de citation

IM

Pagination

306-315

Subventions

Organisme : NHLBI NIH HHS
ID : U01 HL096812
Pays : United States
Organisme : NHLBI NIH HHS
ID : U01 HL096917
Pays : United States
Organisme : NHLBI NIH HHS
ID : U01 HL096902
Pays : United States
Organisme : NHLBI NIH HHS
ID : HHSN268201700002C
Pays : United States
Organisme : NHLBI NIH HHS
ID : HHSN268201700001I
Pays : United States
Organisme : NHLBI NIH HHS
ID : HHSN268201700004I
Pays : United States
Organisme : NHLBI NIH HHS
ID : U01 HL096814
Pays : United States
Organisme : NHLBI NIH HHS
ID : R01 HL070825
Pays : United States
Organisme : NHLBI NIH HHS
ID : HHSN268201700003I
Pays : United States
Organisme : NHLBI NIH HHS
ID : HHSN268201700005C
Pays : United States
Organisme : NHLBI NIH HHS
ID : HHSN268201700001C
Pays : United States
Organisme : NHLBI NIH HHS
ID : HHSN268201700003C
Pays : United States
Organisme : NHLBI NIH HHS
ID : U01 HL096899
Pays : United States
Organisme : NHLBI NIH HHS
ID : HHSN268201700004C
Pays : United States
Organisme : NHLBI NIH HHS
ID : HHSN268201700002I
Pays : United States
Organisme : NHLBI NIH HHS
ID : HHSN268201700005I
Pays : United States

Informations de copyright

© 2021 The Author(s) Published by S. Karger AG, Basel.

Références

J Am Heart Assoc. 2018 Mar 7;7(6):
pubmed: 29514809
Stroke. 2016 Mar;47(3):895-900
pubmed: 26786114
Circulation. 2016 Feb 9;133(6):601-9
pubmed: 26858290
Stroke. 1999 Apr;30(4):736-43
pubmed: 10187871
Ann Epidemiol. 1992 Sep;2(5):723-33
pubmed: 1342324
Proteomics Clin Appl. 2018 May;12(3):e1700067
pubmed: 29281176
J Proteomics. 2010 Jan 3;73(3):649-66
pubmed: 19755178
Immun Ageing. 2012 Sep 17;9(1):20
pubmed: 22985434
Arterioscler Thromb Vasc Biol. 2010 Mar;30(3):599-604
pubmed: 19965782
PLoS One. 2010 Dec 07;5(12):e15004
pubmed: 21165148
Neuroepidemiology. 2010;34(1):34-42
pubmed: 19893327
J Am Heart Assoc. 2018 Nov 6;7(21):e009561
pubmed: 30571385
Thromb Haemost. 2001 Jun;85(6):958-65
pubmed: 11434702
J Thromb Haemost. 2009 Nov;7(11):1774-8
pubmed: 19691480
Am J Kidney Dis. 2007 Dec;50(6):918-26
pubmed: 18037092
Thromb Haemost. 1995 Feb;73(2):256-60
pubmed: 7792740
Thromb Haemost. 2019 Jun;119(6):981-991
pubmed: 30919384
Stat Med. 2009 Aug 15;28(18):2325-37
pubmed: 19499549
Neurology. 2005 May 10;64(9):1539-47
pubmed: 15883314
Thromb Haemost. 1993 Oct 18;70(4):588-94
pubmed: 8115984
Lancet. 2009 Jan 10;373(9658):155-66
pubmed: 19135613
Neuroepidemiology. 2001 May;20(2):96-104
pubmed: 11359076
BMJ. 1996 Jul 13;313(7049):106
pubmed: 8688716
J Thromb Haemost. 2011 Aug;9(8):1475-82
pubmed: 21676170
Thromb Haemost. 1990 Dec 28;64(4):521-5
pubmed: 2084937
Stroke. 2017 Sep;48(9):2353-2360
pubmed: 28765285
Sci Rep. 2017 Oct 27;7(1):14248
pubmed: 29079756
Thromb Haemost. 1989 Feb 28;61(1):15-9
pubmed: 2526384
Science. 2018 Aug 24;361(6404):769-773
pubmed: 30072576
Stroke. 2013 Nov;44(11):3275-85
pubmed: 24085025
Lancet. 2017 Dec 16;390(10113):2673-2734
pubmed: 28735855
Alzheimers Dement. 2015 Jun;11(6):718-26
pubmed: 26045020
N Engl J Med. 2003 Mar 27;348(13):1215-22
pubmed: 12660385
J Thromb Haemost. 2008 Jun;6(6):995-1002
pubmed: 18489431
Adv Exp Med Biol. 1987;214:47-54
pubmed: 2959034
Alzheimers Dement (Amst). 2016;2:1-11
pubmed: 26949733
Ann Intern Med. 2009 May 5;150(9):604-12
pubmed: 19414839
J Clin Epidemiol. 1996 Feb;49(2):223-33
pubmed: 8606324
Mayo Clin Proc. 2018 Feb;93(2):145-154
pubmed: 29329798
Arch Neurol. 1989 Feb;46(2):141-5
pubmed: 2916953
Ann Emerg Med. 2011 Jun;57(6):653-61
pubmed: 20855129
Neurology. 2019 Mar 12;92(11):e1256-e1267
pubmed: 30760633
Alzheimers Dement. 2018 Nov;14(11):1416-1426
pubmed: 30177276
Ann Intern Med. 2014 Dec 2;161(11):785-93
pubmed: 25437406
Blood. 1985 Feb;65(2):444-51
pubmed: 3917696
Neurology. 2014 Sep 30;83(14):1271-6
pubmed: 25209581
Neurology. 2008 Feb 5;70(6):425-30
pubmed: 17898325

Auteurs

Adrienne Tin (A)

Department of Medicine, University of Mississippi Medical Center, Jackson, Mississippi, USA.
Department of Epidemiology, Johns Hopkins Bloomberg School of Public Health, Baltimore, Maryland, USA.

Keenan A Walker (KA)

Laboratory of Behavioral Neuroscience, Intramural Research Program, National Institute on Aging, Baltimore, Maryland, USA.

Jan Bressler (J)

Human Genetics Center, School of Public Health, University of Texas Health Science Center at Houston, Houston, Texas, USA.

B Gwen Windham (BG)

Department of Medicine, University of Mississippi Medical Center, Jackson, Mississippi, USA.

Michael Griswold (M)

Department of Medicine, University of Mississippi Medical Center, Jackson, Mississippi, USA.

Kevin Sullivan (K)

Department of Medicine, University of Mississippi Medical Center, Jackson, Mississippi, USA.

Aozhou Wu (A)

Department of Epidemiology, Johns Hopkins Bloomberg School of Public Health, Baltimore, Maryland, USA.

Rebecca Gottesman (R)

Department of Neurology, Johns Hopkins University, Baltimore, Maryland, USA.

Myriam Fornage (M)

Human Genetics Center, School of Public Health, University of Texas Health Science Center at Houston, Houston, Texas, USA.

Josef Coresh (J)

Department of Epidemiology, Johns Hopkins Bloomberg School of Public Health, Baltimore, Maryland, USA.

A Richey Sharrett (AR)

Department of Epidemiology, Johns Hopkins Bloomberg School of Public Health, Baltimore, Maryland, USA.

Aaron R Folsom (AR)

Division of Epidemiology and Community Health, University of Minnesota, Minneapolis, Minnesota, USA.

Thomas H Mosley (TH)

Department of Medicine, University of Mississippi Medical Center, Jackson, Mississippi, USA.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH